

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.19943385 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 5.62431596 |
| 3 | vocalization behavior (GO:0071625) | 5.60609621 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.47726972 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.45192973 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.43434987 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.41759476 |
| 8 | L-amino acid import (GO:0043092) | 5.30506872 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.26119935 |
| 10 | glutamate secretion (GO:0014047) | 5.19960429 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.97358760 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.94890655 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.94384910 |
| 14 | protein localization to synapse (GO:0035418) | 4.91473003 |
| 15 | cerebellar granule cell differentiation (GO:0021707) | 4.80217935 |
| 16 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.71237256 |
| 17 | neuronal action potential propagation (GO:0019227) | 4.71104222 |
| 18 | neuron cell-cell adhesion (GO:0007158) | 4.67813128 |
| 19 | amino acid import (GO:0043090) | 4.66417509 |
| 20 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.57613965 |
| 21 | exploration behavior (GO:0035640) | 4.55782182 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.52012799 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 4.48606475 |
| 24 | glutamate receptor signaling pathway (GO:0007215) | 4.47929268 |
| 25 | * neurotransmitter secretion (GO:0007269) | 4.45040400 |
| 26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.41925376 |
| 27 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.40243556 |
| 28 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.29276308 |
| 29 | potassium ion homeostasis (GO:0055075) | 4.28180880 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 4.22070615 |
| 31 | proline transport (GO:0015824) | 4.16394439 |
| 32 | potassium ion import (GO:0010107) | 4.14054037 |
| 33 | regulation of voltage-gated calcium channel activity (GO:1901385) | 4.08975709 |
| 34 | neuron-neuron synaptic transmission (GO:0007270) | 4.06430561 |
| 35 | central nervous system myelination (GO:0022010) | 4.02915452 |
| 36 | axon ensheathment in central nervous system (GO:0032291) | 4.02915452 |
| 37 | gamma-aminobutyric acid transport (GO:0015812) | 4.01007665 |
| 38 | layer formation in cerebral cortex (GO:0021819) | 3.95983048 |
| 39 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.95875926 |
| 40 | long-term memory (GO:0007616) | 3.95489882 |
| 41 | dendritic spine morphogenesis (GO:0060997) | 3.87724380 |
| 42 | neuron recognition (GO:0008038) | 3.85883050 |
| 43 | regulation of ARF protein signal transduction (GO:0032012) | 3.84163294 |
| 44 | cellular sodium ion homeostasis (GO:0006883) | 3.80699932 |
| 45 | regulation of synapse structural plasticity (GO:0051823) | 3.80656970 |
| 46 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.80292271 |
| 47 | regulation of synapse maturation (GO:0090128) | 3.78992549 |
| 48 | cellular potassium ion homeostasis (GO:0030007) | 3.78658648 |
| 49 | regulation of postsynaptic membrane potential (GO:0060078) | 3.74980660 |
| 50 | * neurotransmitter transport (GO:0006836) | 3.74663716 |
| 51 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.73525723 |
| 52 | positive regulation of membrane potential (GO:0045838) | 3.72871972 |
| 53 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.71679866 |
| 54 | regulation of synaptic plasticity (GO:0048167) | 3.68520474 |
| 55 | synaptic vesicle endocytosis (GO:0048488) | 3.68441462 |
| 56 | positive regulation of synapse maturation (GO:0090129) | 3.62616142 |
| 57 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.60239452 |
| 58 | regulation of vesicle fusion (GO:0031338) | 3.60106772 |
| 59 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.57131589 |
| 60 | long-term synaptic potentiation (GO:0060291) | 3.56622020 |
| 61 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.54501641 |
| 62 | transmission of nerve impulse (GO:0019226) | 3.53807384 |
| 63 | neurotransmitter uptake (GO:0001504) | 3.53616574 |
| 64 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.53545751 |
| 65 | regulation of neurotransmitter secretion (GO:0046928) | 3.52263514 |
| 66 | acidic amino acid transport (GO:0015800) | 3.42923309 |
| 67 | * regulation of neurotransmitter levels (GO:0001505) | 3.41781176 |
| 68 | axonal fasciculation (GO:0007413) | 3.39788769 |
| 69 | activation of protein kinase A activity (GO:0034199) | 3.36654804 |
| 70 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.35961626 |
| 71 | fear response (GO:0042596) | 3.27548797 |
| 72 | neuromuscular synaptic transmission (GO:0007274) | 3.27210265 |
| 73 | sodium ion export (GO:0071436) | 3.27161963 |
| 74 | vesicle docking involved in exocytosis (GO:0006904) | 3.26231829 |
| 75 | behavioral fear response (GO:0001662) | 3.25643303 |
| 76 | behavioral defense response (GO:0002209) | 3.25643303 |
| 77 | regulation of neurotransmitter transport (GO:0051588) | 3.24696632 |
| 78 | synaptic vesicle transport (GO:0048489) | 3.24135123 |
| 79 | establishment of synaptic vesicle localization (GO:0097480) | 3.24135123 |
| 80 | detection of calcium ion (GO:0005513) | 3.22560059 |
| 81 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.22141766 |
| 82 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.21202814 |
| 83 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.20782780 |
| 84 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.20560910 |
| 85 | response to histamine (GO:0034776) | 3.19534005 |
| 86 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.18672728 |
| 87 | neuromuscular process controlling posture (GO:0050884) | 3.18596959 |
| 88 | membrane depolarization (GO:0051899) | 3.18395519 |
| 89 | positive regulation of neurotransmitter transport (GO:0051590) | 3.18007209 |
| 90 | cell communication involved in cardiac conduction (GO:0086065) | 3.15317115 |
| 91 | learning (GO:0007612) | 3.14437451 |
| 92 | postsynaptic membrane organization (GO:0001941) | 3.14054499 |
| 93 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.13977702 |
| 94 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.12228045 |
| 95 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.11041222 |
| 96 | regulation of synaptic transmission (GO:0050804) | 3.10556871 |
| 97 | regulation of exocytosis (GO:0017157) | 3.10470385 |
| 98 | neuromuscular process (GO:0050905) | 3.09773774 |
| 99 | auditory behavior (GO:0031223) | 3.08595345 |
| 100 | cell differentiation in hindbrain (GO:0021533) | 3.08360294 |
| 101 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.07549759 |
| 102 | regulation of glutamate secretion (GO:0014048) | 3.06685951 |
| 103 | neuromuscular process controlling balance (GO:0050885) | 3.06481979 |
| 104 | vesicle docking (GO:0048278) | 3.06235367 |
| 105 | regulation of dendritic spine development (GO:0060998) | 3.06178600 |
| 106 | * synaptic transmission (GO:0007268) | 3.05883871 |
| 107 | positive regulation of dendritic spine development (GO:0060999) | 3.05859166 |
| 108 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.04701624 |
| 109 | L-glutamate transport (GO:0015813) | 3.03876273 |
| 110 | vesicle transport along microtubule (GO:0047496) | 3.03521861 |
| 111 | positive regulation of synaptic transmission (GO:0050806) | 3.01900721 |
| 112 | intraspecies interaction between organisms (GO:0051703) | 3.01624619 |
| 113 | social behavior (GO:0035176) | 3.01624619 |
| 114 | presynaptic membrane assembly (GO:0097105) | 3.01417959 |
| 115 | innervation (GO:0060384) | 3.00714272 |
| 116 | cell communication by electrical coupling (GO:0010644) | 3.00264467 |
| 117 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.99899968 |
| 118 | membrane depolarization during action potential (GO:0086010) | 2.99719865 |
| 119 | mating behavior (GO:0007617) | 2.99018419 |
| 120 | dendritic spine organization (GO:0097061) | 2.97361767 |
| 121 | synapse assembly (GO:0007416) | 2.94641721 |
| 122 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.94229153 |
| 123 | glycine transport (GO:0015816) | 2.93678967 |
| 124 | behavioral response to cocaine (GO:0048148) | 2.93372964 |
| 125 | membrane hyperpolarization (GO:0060081) | 2.90132266 |
| 126 | neuronal ion channel clustering (GO:0045161) | 2.89397987 |
| 127 | long term synaptic depression (GO:0060292) | 2.88578957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.60134045 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.60805740 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.26123351 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.21495792 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.16868586 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.80797067 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.80320845 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.80320845 |
| 9 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.77599089 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.74206884 |
| 11 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.60223900 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.59769531 |
| 13 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.56697088 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.56118472 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.53975798 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.52868105 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.39878969 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.37006500 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.30991321 |
| 20 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.26514216 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26022490 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.25141430 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.23460061 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.17310601 |
| 25 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 2.01336406 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.99702680 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.98932879 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.94293812 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.92903899 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.88646304 |
| 31 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.83134104 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.83027794 |
| 33 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.80851542 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.72384720 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.60681851 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.60032517 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.57179042 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.57007794 |
| 39 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.50480102 |
| 40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.50101805 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.49637274 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.45871968 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41732205 |
| 44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39307949 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34196794 |
| 46 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34139116 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33086053 |
| 48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32096310 |
| 49 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31338044 |
| 50 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30609522 |
| 51 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.29985623 |
| 52 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29136096 |
| 53 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.29119151 |
| 54 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.28790794 |
| 55 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.27808500 |
| 56 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27519746 |
| 57 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.24355047 |
| 58 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23364880 |
| 59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22129950 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22052477 |
| 61 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.21854534 |
| 62 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.20456038 |
| 63 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.19894050 |
| 64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18271816 |
| 65 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16414020 |
| 66 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15932221 |
| 67 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.15617995 |
| 68 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15508637 |
| 69 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.14347105 |
| 70 | FUS_26573619_Chip-Seq_HEK293_Human | 1.13818972 |
| 71 | * AR_19668381_ChIP-Seq_PC3_Human | 1.13250406 |
| 72 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.10971395 |
| 73 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10559312 |
| 74 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07462165 |
| 75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07344884 |
| 76 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05559734 |
| 77 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05091541 |
| 78 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03794667 |
| 79 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03582625 |
| 80 | VDR_22108803_ChIP-Seq_LS180_Human | 1.03248285 |
| 81 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.03233746 |
| 82 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.03033073 |
| 83 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02568000 |
| 84 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02109425 |
| 85 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01605857 |
| 86 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01586174 |
| 87 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00487409 |
| 88 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00353695 |
| 89 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00270403 |
| 90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00180276 |
| 91 | JUN_21703547_ChIP-Seq_K562_Human | 0.99268502 |
| 92 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98727749 |
| 93 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98487781 |
| 94 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96107645 |
| 95 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.95316560 |
| 96 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94997177 |
| 97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94237416 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.92723453 |
| 99 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.91640189 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91476973 |
| 101 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90993418 |
| 102 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90753847 |
| 103 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90523899 |
| 104 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90296427 |
| 105 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90065176 |
| 106 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.89449672 |
| 107 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89404641 |
| 108 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.88671767 |
| 109 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88501744 |
| 110 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87840454 |
| 111 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87483424 |
| 112 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86279088 |
| 113 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.85772227 |
| 114 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85114392 |
| 115 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.84336087 |
| 116 | KDM2B_26808549_Chip-Seq_K562_Human | 0.83885472 |
| 117 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83870074 |
| 118 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.83860597 |
| 119 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83703130 |
| 120 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83695987 |
| 121 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.83658362 |
| 122 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.83589340 |
| 123 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.81563173 |
| 124 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.80958432 |
| 125 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.80952453 |
| 126 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.79878661 |
| 127 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77866481 |
| 128 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77437424 |
| 129 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75931566 |
| 130 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.75910146 |
| 131 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.75376715 |
| 132 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.75293892 |
| 133 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.74821679 |
| 134 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.74756468 |
| 135 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.74127553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.49515561 |
| 2 | MP0003880_abnormal_central_pattern | 4.97965373 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.21978457 |
| 4 | MP0004270_analgesia | 3.69782596 |
| 5 | MP0009745_abnormal_behavioral_response | 3.64284498 |
| 6 | MP0002822_catalepsy | 3.46277529 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.39643543 |
| 8 | * MP0002064_seizures | 3.24832859 |
| 9 | MP0009046_muscle_twitch | 3.01472267 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.00573680 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.90174694 |
| 12 | MP0002272_abnormal_nervous_system | 2.68197183 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.66981427 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.62574313 |
| 15 | MP0001440_abnormal_grooming_behavior | 2.49427540 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.46356226 |
| 17 | MP0001486_abnormal_startle_reflex | 2.42177151 |
| 18 | MP0002736_abnormal_nociception_after | 2.42091609 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.32793323 |
| 20 | MP0002733_abnormal_thermal_nociception | 2.09794838 |
| 21 | MP0003329_amyloid_beta_deposits | 2.08748103 |
| 22 | MP0001970_abnormal_pain_threshold | 2.03432410 |
| 23 | MP0002067_abnormal_sensory_capabilities | 1.95890403 |
| 24 | MP0006276_abnormal_autonomic_nervous | 1.93039961 |
| 25 | MP0004858_abnormal_nervous_system | 1.90081507 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.83928660 |
| 27 | MP0008569_lethality_at_weaning | 1.82985042 |
| 28 | MP0002184_abnormal_innervation | 1.82019533 |
| 29 | MP0005386_behavior/neurological_phenoty | 1.77845659 |
| 30 | MP0004924_abnormal_behavior | 1.77845659 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.70759170 |
| 32 | MP0000778_abnormal_nervous_system | 1.70264207 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.65428477 |
| 34 | MP0004811_abnormal_neuron_physiology | 1.64263404 |
| 35 | MP0001529_abnormal_vocalization | 1.52667631 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.51507371 |
| 37 | MP0010386_abnormal_urinary_bladder | 1.49563050 |
| 38 | MP0001905_abnormal_dopamine_level | 1.49478085 |
| 39 | MP0000955_abnormal_spinal_cord | 1.48282853 |
| 40 | MP0003879_abnormal_hair_cell | 1.46449133 |
| 41 | MP0001984_abnormal_olfaction | 1.45973193 |
| 42 | MP0002066_abnormal_motor_capabilities/c | 1.40724687 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 1.38679211 |
| 44 | MP0003787_abnormal_imprinting | 1.37640725 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 1.37413919 |
| 46 | MP0003633_abnormal_nervous_system | 1.33553289 |
| 47 | * MP0002882_abnormal_neuron_morphology | 1.32662092 |
| 48 | MP0004885_abnormal_endolymph | 1.28333859 |
| 49 | MP0004142_abnormal_muscle_tone | 1.24533938 |
| 50 | MP0003122_maternal_imprinting | 1.23263108 |
| 51 | MP0001502_abnormal_circadian_rhythm | 1.20236751 |
| 52 | MP0003631_nervous_system_phenotype | 1.15054550 |
| 53 | MP0008872_abnormal_physiological_respon | 1.14611638 |
| 54 | MP0001188_hyperpigmentation | 1.08388485 |
| 55 | MP0002638_abnormal_pupillary_reflex | 1.04897060 |
| 56 | * MP0002152_abnormal_brain_morphology | 1.03348356 |
| 57 | MP0000751_myopathy | 1.00903858 |
| 58 | MP0004147_increased_porphyrin_level | 1.00509870 |
| 59 | MP0000013_abnormal_adipose_tissue | 0.99696809 |
| 60 | MP0000604_amyloidosis | 0.98499965 |
| 61 | MP0005535_abnormal_body_temperature | 0.95081309 |
| 62 | MP0002069_abnormal_eating/drinking_beha | 0.95044887 |
| 63 | MP0008874_decreased_physiological_sensi | 0.94737479 |
| 64 | MP0001346_abnormal_lacrimal_gland | 0.94500621 |
| 65 | MP0004145_abnormal_muscle_electrophysio | 0.93058918 |
| 66 | MP0002229_neurodegeneration | 0.90677199 |
| 67 | MP0008877_abnormal_DNA_methylation | 0.88738681 |
| 68 | MP0001348_abnormal_lacrimal_gland | 0.87651216 |
| 69 | MP0004484_altered_response_of | 0.84166915 |
| 70 | MP0002876_abnormal_thyroid_physiology | 0.83117762 |
| 71 | MP0004085_abnormal_heartbeat | 0.82526728 |
| 72 | MP0004742_abnormal_vestibular_system | 0.81325963 |
| 73 | MP0001963_abnormal_hearing_physiology | 0.81148169 |
| 74 | MP0001177_atelectasis | 0.80876483 |
| 75 | MP0003632_abnormal_nervous_system | 0.80522986 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 0.79973914 |
| 77 | MP0003075_altered_response_to | 0.79213436 |
| 78 | MP0003634_abnormal_glial_cell | 0.76286273 |
| 79 | MP0001986_abnormal_taste_sensitivity | 0.75189202 |
| 80 | MP0004215_abnormal_myocardial_fiber | 0.74252281 |
| 81 | MP0005499_abnormal_olfactory_system | 0.73000017 |
| 82 | MP0005394_taste/olfaction_phenotype | 0.73000017 |
| 83 | MP0004510_myositis | 0.71143472 |
| 84 | MP0002752_abnormal_somatic_nervous | 0.70640596 |
| 85 | MP0003690_abnormal_glial_cell | 0.67371890 |
| 86 | MP0001664_abnormal_digestion | 0.66057266 |
| 87 | MP0000920_abnormal_myelination | 0.65596555 |
| 88 | MP0010234_abnormal_vibrissa_follicle | 0.65468695 |
| 89 | MP0002090_abnormal_vision | 0.65193191 |
| 90 | MP0004130_abnormal_muscle_cell | 0.63497314 |
| 91 | MP0008961_abnormal_basal_metabolism | 0.63141392 |
| 92 | MP0000631_abnormal_neuroendocrine_gland | 0.61707699 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.59918860 |
| 94 | MP0005409_darkened_coat_color | 0.57761563 |
| 95 | MP0001485_abnormal_pinna_reflex | 0.56987805 |
| 96 | MP0005623_abnormal_meninges_morphology | 0.56324109 |
| 97 | MP0010768_mortality/aging | 0.53510590 |
| 98 | MP0001943_abnormal_respiration | 0.53048643 |
| 99 | MP0003172_abnormal_lysosome_physiology | 0.52838370 |
| 100 | MP0000579_abnormal_nail_morphology | 0.52392923 |
| 101 | MP0003283_abnormal_digestive_organ | 0.52211137 |
| 102 | MP0002082_postnatal_lethality | 0.52193909 |
| 103 | MP0004233_abnormal_muscle_weight | 0.51704289 |
| 104 | MP0005187_abnormal_penis_morphology | 0.51428793 |
| 105 | MP0003137_abnormal_impulse_conducting | 0.51356434 |
| 106 | MP0003123_paternal_imprinting | 0.50160956 |
| 107 | MP0004043_abnormal_pH_regulation | 0.49447393 |
| 108 | MP0010769_abnormal_survival | 0.48355917 |
| 109 | MP0003956_abnormal_body_size | 0.48025777 |
| 110 | MP0003121_genomic_imprinting | 0.47673327 |
| 111 | MP0000569_abnormal_digit_pigmentation | 0.47225594 |
| 112 | MP0010770_preweaning_lethality | 0.46998851 |
| 113 | MP0000026_abnormal_inner_ear | 0.45676444 |
| 114 | * MP0003861_abnormal_nervous_system | 0.44625336 |
| 115 | MP0002873_normal_phenotype | 0.43894630 |
| 116 | MP0005166_decreased_susceptibility_to | 0.43160284 |
| 117 | MP0002169_no_abnormal_phenotype | 0.42212950 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.41267505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.48834047 |
| 2 | Myokymia (HP:0002411) | 6.84738552 |
| 3 | Focal seizures (HP:0007359) | 6.09464249 |
| 4 | Visual hallucinations (HP:0002367) | 5.93619273 |
| 5 | Atonic seizures (HP:0010819) | 5.20703245 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.95591197 |
| 7 | Absence seizures (HP:0002121) | 4.69075708 |
| 8 | Febrile seizures (HP:0002373) | 4.68758291 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.37044809 |
| 10 | Dialeptic seizures (HP:0011146) | 4.29922869 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.25263093 |
| 12 | Hyperventilation (HP:0002883) | 3.77695831 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.76737265 |
| 14 | Action tremor (HP:0002345) | 3.74602016 |
| 15 | Amblyopia (HP:0000646) | 3.66604432 |
| 16 | Cerebral hypomyelination (HP:0006808) | 3.54639708 |
| 17 | Obstructive sleep apnea (HP:0002870) | 3.51428512 |
| 18 | Broad-based gait (HP:0002136) | 3.50185097 |
| 19 | Tetraplegia (HP:0002445) | 3.37050596 |
| 20 | Cerebral inclusion bodies (HP:0100314) | 3.36514332 |
| 21 | Poor eye contact (HP:0000817) | 3.33918517 |
| 22 | Anxiety (HP:0000739) | 3.24082515 |
| 23 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.23292562 |
| 24 | Depression (HP:0000716) | 3.22488610 |
| 25 | Dysmetria (HP:0001310) | 3.14515817 |
| 26 | Gaze-evoked nystagmus (HP:0000640) | 3.13225247 |
| 27 | Dysdiadochokinesis (HP:0002075) | 3.11890003 |
| 28 | Truncal ataxia (HP:0002078) | 3.10314801 |
| 29 | Neurofibrillary tangles (HP:0002185) | 3.08667855 |
| 30 | Impaired social interactions (HP:0000735) | 3.06626601 |
| 31 | Abnormal social behavior (HP:0012433) | 3.06626601 |
| 32 | Ankle clonus (HP:0011448) | 3.00002729 |
| 33 | Progressive inability to walk (HP:0002505) | 2.91662437 |
| 34 | Abnormal eating behavior (HP:0100738) | 2.86322956 |
| 35 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.85428736 |
| 36 | Postural instability (HP:0002172) | 2.82762261 |
| 37 | Papilledema (HP:0001085) | 2.81560661 |
| 38 | Drooling (HP:0002307) | 2.80981384 |
| 39 | Excessive salivation (HP:0003781) | 2.80981384 |
| 40 | Diplopia (HP:0000651) | 2.78994291 |
| 41 | Abnormality of binocular vision (HP:0011514) | 2.78994291 |
| 42 | Akinesia (HP:0002304) | 2.77381194 |
| 43 | Mutism (HP:0002300) | 2.76079258 |
| 44 | Hemiparesis (HP:0001269) | 2.72901689 |
| 45 | Clonus (HP:0002169) | 2.65644673 |
| 46 | Peripheral hypomyelination (HP:0007182) | 2.63178226 |
| 47 | Epileptiform EEG discharges (HP:0011182) | 2.59344164 |
| 48 | Sleep apnea (HP:0010535) | 2.56974974 |
| 49 | Impaired smooth pursuit (HP:0007772) | 2.56779691 |
| 50 | Apathy (HP:0000741) | 2.56441938 |
| 51 | Abnormality of the lower motor neuron (HP:0002366) | 2.54666746 |
| 52 | Urinary urgency (HP:0000012) | 2.48675473 |
| 53 | EEG with generalized epileptiform discharges (HP:0011198) | 2.46763570 |
| 54 | Termporal pattern (HP:0011008) | 2.46644115 |
| 55 | Insidious onset (HP:0003587) | 2.46644115 |
| 56 | Absent speech (HP:0001344) | 2.46499379 |
| 57 | Bradykinesia (HP:0002067) | 2.45301909 |
| 58 | Delusions (HP:0000746) | 2.43789892 |
| 59 | Scanning speech (HP:0002168) | 2.40567482 |
| 60 | Insomnia (HP:0100785) | 2.40086659 |
| 61 | Spastic tetraparesis (HP:0001285) | 2.38691984 |
| 62 | Inability to walk (HP:0002540) | 2.38496074 |
| 63 | Genetic anticipation (HP:0003743) | 2.36817626 |
| 64 | Spastic gait (HP:0002064) | 2.36156239 |
| 65 | Status epilepticus (HP:0002133) | 2.35776752 |
| 66 | Stereotypic behavior (HP:0000733) | 2.31934790 |
| 67 | Generalized myoclonic seizures (HP:0002123) | 2.29943742 |
| 68 | Hypsarrhythmia (HP:0002521) | 2.29605524 |
| 69 | Diminished motivation (HP:0000745) | 2.28104530 |
| 70 | Choreoathetosis (HP:0001266) | 2.27375235 |
| 71 | Hemiplegia (HP:0002301) | 2.26015482 |
| 72 | Intention tremor (HP:0002080) | 2.25169977 |
| 73 | Abnormality of the corticospinal tract (HP:0002492) | 2.24952319 |
| 74 | Torticollis (HP:0000473) | 2.24634215 |
| 75 | CNS hypomyelination (HP:0003429) | 2.24291872 |
| 76 | Focal dystonia (HP:0004373) | 2.23995679 |
| 77 | Pheochromocytoma (HP:0002666) | 2.23150603 |
| 78 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.19303207 |
| 79 | Agitation (HP:0000713) | 2.17568278 |
| 80 | Polyphagia (HP:0002591) | 2.16866224 |
| 81 | Psychosis (HP:0000709) | 2.16820901 |
| 82 | Abnormality of saccadic eye movements (HP:0000570) | 2.10351650 |
| 83 | Impaired vibratory sensation (HP:0002495) | 2.10030040 |
| 84 | Rapidly progressive (HP:0003678) | 2.09287892 |
| 85 | Fetal akinesia sequence (HP:0001989) | 2.08624146 |
| 86 | Ventricular fibrillation (HP:0001663) | 2.04916315 |
| 87 | Megalencephaly (HP:0001355) | 2.04901695 |
| 88 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.04392478 |
| 89 | Lower limb muscle weakness (HP:0007340) | 2.04195790 |
| 90 | Limb dystonia (HP:0002451) | 1.99154301 |
| 91 | Gait ataxia (HP:0002066) | 1.98535068 |
| 92 | Neuroendocrine neoplasm (HP:0100634) | 1.95905820 |
| 93 | Hyperthyroidism (HP:0000836) | 1.94928805 |
| 94 | Dysmetric saccades (HP:0000641) | 1.93971856 |
| 95 | Abnormality of salivation (HP:0100755) | 1.93959265 |
| 96 | Increased circulating renin level (HP:0000848) | 1.93941225 |
| 97 | Blue irides (HP:0000635) | 1.93089665 |
| 98 | Craniofacial dystonia (HP:0012179) | 1.92104835 |
| 99 | Bundle branch block (HP:0011710) | 1.91668616 |
| 100 | Memory impairment (HP:0002354) | 1.91210971 |
| 101 | Hypoventilation (HP:0002791) | 1.90794893 |
| 102 | Retinal dysplasia (HP:0007973) | 1.89493384 |
| 103 | Neuronal loss in central nervous system (HP:0002529) | 1.87453239 |
| 104 | Incomplete penetrance (HP:0003829) | 1.86083011 |
| 105 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.84910003 |
| 106 | Amyotrophic lateral sclerosis (HP:0007354) | 1.84654429 |
| 107 | Lower limb amyotrophy (HP:0007210) | 1.83925737 |
| 108 | Split foot (HP:0001839) | 1.82603726 |
| 109 | Spinal canal stenosis (HP:0003416) | 1.78355871 |
| 110 | Exotropia (HP:0000577) | 1.77664724 |
| 111 | Protruding tongue (HP:0010808) | 1.76953041 |
| 112 | Unsteady gait (HP:0002317) | 1.76913444 |
| 113 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.76263970 |
| 114 | Annular pancreas (HP:0001734) | 1.75838864 |
| 115 | Slow saccadic eye movements (HP:0000514) | 1.75316691 |
| 116 | Rigidity (HP:0002063) | 1.74132670 |
| 117 | Bronchomalacia (HP:0002780) | 1.72528805 |
| 118 | Hypothermia (HP:0002045) | 1.72467462 |
| 119 | Gait imbalance (HP:0002141) | 1.72370799 |
| 120 | Lower limb asymmetry (HP:0100559) | 1.71715964 |
| 121 | Aplasia of the phalanges of the hand (HP:0009802) | 1.69207610 |
| 122 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.68321175 |
| 123 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.68321175 |
| 124 | Inappropriate behavior (HP:0000719) | 1.67338233 |
| 125 | Anosmia (HP:0000458) | 1.66121498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.69795672 |
| 2 | EPHA4 | 4.40651301 |
| 3 | MAP3K9 | 3.92920933 |
| 4 | MAP3K4 | 3.13232583 |
| 5 | MINK1 | 2.73465680 |
| 6 | MAP2K7 | 2.62387816 |
| 7 | MAP3K12 | 2.52585328 |
| 8 | RIPK4 | 2.47569107 |
| 9 | KSR2 | 2.37130329 |
| 10 | MARK1 | 2.34679361 |
| 11 | NTRK1 | 2.33438814 |
| 12 | DAPK2 | 2.26650916 |
| 13 | PNCK | 2.22333993 |
| 14 | MAP2K4 | 2.04620284 |
| 15 | PAK6 | 1.99262978 |
| 16 | ARAF | 1.98958520 |
| 17 | NTRK2 | 1.93547414 |
| 18 | GRK5 | 1.88664699 |
| 19 | PLK2 | 1.75443631 |
| 20 | KSR1 | 1.70532307 |
| 21 | PRKD3 | 1.66716277 |
| 22 | CASK | 1.66157081 |
| 23 | MAP3K13 | 1.64907267 |
| 24 | DAPK1 | 1.58988714 |
| 25 | CAMKK1 | 1.53859709 |
| 26 | CDK5 | 1.49244281 |
| 27 | SIK2 | 1.48147956 |
| 28 | TNIK | 1.39381071 |
| 29 | FES | 1.33410816 |
| 30 | RIPK1 | 1.32559094 |
| 31 | PRKCG | 1.26490896 |
| 32 | MAP3K2 | 1.18031196 |
| 33 | STK38 | 1.17950962 |
| 34 | CDK19 | 1.15330716 |
| 35 | PTK2B | 1.15185403 |
| 36 | PRPF4B | 1.11773103 |
| 37 | CAMK2A | 1.09186477 |
| 38 | MAPK13 | 1.08478123 |
| 39 | RAF1 | 1.06198775 |
| 40 | BMPR2 | 1.04359367 |
| 41 | NEK6 | 1.03876458 |
| 42 | UHMK1 | 1.02491513 |
| 43 | NME1 | 0.99385451 |
| 44 | CAMKK2 | 0.97221207 |
| 45 | LATS2 | 0.96717931 |
| 46 | TYRO3 | 0.93725208 |
| 47 | CAMK1 | 0.92010991 |
| 48 | CAMK2B | 0.90326462 |
| 49 | GRK7 | 0.82927134 |
| 50 | CDK18 | 0.81533316 |
| 51 | CDK14 | 0.81400351 |
| 52 | CDK15 | 0.79991583 |
| 53 | FGR | 0.79278045 |
| 54 | BRSK1 | 0.79087349 |
| 55 | STK11 | 0.76079828 |
| 56 | PAK3 | 0.75622305 |
| 57 | PHKG2 | 0.75317050 |
| 58 | PHKG1 | 0.75317050 |
| 59 | DYRK1A | 0.73542263 |
| 60 | SGK494 | 0.71691511 |
| 61 | SGK223 | 0.71691511 |
| 62 | MAP3K1 | 0.69474130 |
| 63 | CDK11A | 0.69392125 |
| 64 | RET | 0.68074435 |
| 65 | OXSR1 | 0.67887528 |
| 66 | MAP3K11 | 0.65963429 |
| 67 | PINK1 | 0.64156912 |
| 68 | LMTK2 | 0.63920236 |
| 69 | PKN1 | 0.63460416 |
| 70 | PRKCH | 0.63199537 |
| 71 | PRKCE | 0.63166531 |
| 72 | SGK1 | 0.62116685 |
| 73 | MAP2K1 | 0.61509312 |
| 74 | CSNK1G2 | 0.61468232 |
| 75 | CAMK2D | 0.57476785 |
| 76 | MUSK | 0.57149821 |
| 77 | LIMK1 | 0.56188850 |
| 78 | TNK2 | 0.55678333 |
| 79 | PDK1 | 0.55358386 |
| 80 | FER | 0.54298676 |
| 81 | CAMK2G | 0.52123771 |
| 82 | PDPK1 | 0.51825348 |
| 83 | SGK2 | 0.51441025 |
| 84 | CAMK1G | 0.49609914 |
| 85 | TAOK1 | 0.48712744 |
| 86 | MAP3K6 | 0.46942966 |
| 87 | GRK6 | 0.46847451 |
| 88 | PRKCZ | 0.45382216 |
| 89 | BRAF | 0.45369279 |
| 90 | MARK2 | 0.44633987 |
| 91 | ALK | 0.44285391 |
| 92 | FGFR2 | 0.43472510 |
| 93 | MOS | 0.42681367 |
| 94 | IRAK2 | 0.41724157 |
| 95 | RPS6KA3 | 0.41327896 |
| 96 | FYN | 0.40426268 |
| 97 | MAP3K7 | 0.40196135 |
| 98 | ROCK2 | 0.39219839 |
| 99 | MAPK10 | 0.38809626 |
| 100 | SGK3 | 0.37278653 |
| 101 | CCNB1 | 0.36554099 |
| 102 | DAPK3 | 0.35131783 |
| 103 | ADRBK1 | 0.35062000 |
| 104 | SCYL2 | 0.34762622 |
| 105 | TESK1 | 0.34338663 |
| 106 | WNK1 | 0.34099846 |
| 107 | PRKCA | 0.33133902 |
| 108 | CAMK4 | 0.31122804 |
| 109 | PRKCB | 0.29831753 |
| 110 | WNK3 | 0.29694723 |
| 111 | MAPK12 | 0.28074774 |
| 112 | PRKG2 | 0.24239720 |
| 113 | MAPK8 | 0.22978488 |
| 114 | ERBB2 | 0.22554302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.88331324 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.34413968 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.85900316 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.76711898 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.69925620 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.68846484 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.67791431 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.59238966 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.59108020 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.42837021 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.27509094 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.26241942 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.18115992 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.98638854 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.94950505 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.90326332 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.89755369 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.89459305 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.83861225 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.83545925 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.79853510 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.79772792 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.67152350 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66173665 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.60488599 |
| 26 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.59835693 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.58494590 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.50409722 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.50358069 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34780229 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.31956784 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.28690130 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.23543539 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.21310819 |
| 35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16286948 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.16228373 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.15201070 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13278299 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12427193 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.07311591 |
| 41 | Melanogenesis_Homo sapiens_hsa04916 | 1.04290563 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02081854 |
| 43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.01431879 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 0.97534069 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96564272 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95688189 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 0.94469502 |
| 48 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.92866376 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.92363050 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.91366322 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89118651 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88321143 |
| 53 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86939781 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82967959 |
| 55 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.81167744 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80677031 |
| 57 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79292779 |
| 58 | Phototransduction_Homo sapiens_hsa04744 | 0.77660598 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77445190 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69939979 |
| 61 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67748817 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67273645 |
| 63 | Parkinsons disease_Homo sapiens_hsa05012 | 0.63736030 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62860648 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62037181 |
| 66 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61843799 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60325131 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.58095618 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56758417 |
| 70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55352008 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52066933 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51132563 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50541960 |
| 74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49431788 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 0.49231475 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49132516 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.48341386 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46762741 |
| 79 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46683188 |
| 80 | Alcoholism_Homo sapiens_hsa05034 | 0.45129920 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43970801 |
| 82 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43658777 |
| 83 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.41745344 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38379881 |
| 85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37450848 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.36241493 |
| 87 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35596266 |
| 88 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35032541 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.32909660 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.32609434 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.31788869 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31713124 |
| 93 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31594701 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30909500 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.29970221 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29835258 |
| 97 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29676280 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29171626 |
| 99 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.28946612 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28754686 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | 0.26981070 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26117072 |
| 103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24929649 |
| 104 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.24451543 |
| 105 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23247435 |
| 106 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.23242793 |
| 107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.22657737 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.22316719 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21589264 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.20565598 |
| 111 | Tight junction_Homo sapiens_hsa04530 | 0.20403900 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.18676328 |
| 113 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.16022743 |
| 114 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.14839822 |
| 115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.13815592 |

